Zynex, Inc.
ZYXI
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device thaā¦ read more
Healthcare
Medical Distribution
21 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.04
Price-0.95%
-$0.01
1Y
Price
Market Cap
$31.509m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-46.1%
EBITDA Margin-89.9%
Net Profit Margin-27.9%
Free Cash Flow MarginRevenue
$144.808m
-24.7%
1y CAGR-1.3%
3y CAGR+4.4%
5y CAGREarnings
-$28.662m
-1057.3%
1y CAGR-389.8%
3y CAGR-292.4%
5y CAGREPS
-$0.93
-1133.3%
1y CAGR-412.9%
3y CAGR-307.2%
5y CAGRBook Value
$1.261m
$85.935m
Assets$84.674m
Liabilities$72.460m
DebtDebt to Assets
84.3%
-4x
Debt to EBITDAFree Cash Flow
-$7.669m
-163.2%
1y CAGR-55.2%
3y CAGR-13.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company